Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer
PHASE3
Anthracycline-containing regimens are recommended as adjuvant treatment for...
Predictive Model of Therapy Outcomes in Breast Cancer Patients
N/A
Patients with breast cancer, who are treated with curative intent, have a c...
Status
Completed
Location
Charing Cross Hospital
Start Date
2012-02
Trial ID
NCT01563211
Studying the Benefits of Adjuvant Sequential vs. Combined Taxane Based Chemotherapy, Followed by Different Biological Treatment Strategies in Early, HER2-positive Breast Cancer
PHASE3
This is an open-label, multicenter randomized controlled, Phase III study c...
Status
Completed
Location
Frauenklinik der Universität München Campus Innenstadt
Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)
PHASE4
Triple-negative breast cancer (TNBC) is a term applied to breast cancer cas...